• About
  • Subscribe
  • Advertise
  • Contact
Monday, January 19, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

Strengthening NDIS support for Aussies with vision impairment

by Jemila Kanu
July 7, 2025
in Associations, Feature, Local, Low vision aids, Ophthalmic Careers, Ophthalmic education, Ophthalmic insights, Ophthalmic organisations, Orthoptics Australia, Orthoptists
Reading Time: 5 mins read
A A
Changes to NDIS legislation have made it difficult for people to access vital orthoptic care. Images: Jemila Kanu.

Changes to NDIS legislation have made it difficult for people to access vital orthoptic care. Images: Jemila Kanu.

Share on FacebookShare on Twitter

Orthoptists can play a key role in supporting individuals with complex vision needs, but they also need the support of an NDIS that does a better job of assisting people with disabilities to live ordinary lives, writes Ms Jemila Kanu.

Jemila Kanu.

As Australia’s world-leading National Disability Insurance Scheme (NDIS) continues to evolve, there are opportunities to enhance support for individuals with low vision and neurological vision impairments, particularly through improved recognition of the functional impacts of vision loss and the critical services that enable full participation in daily life.

A significant gap lies in the awareness and integration of vision-related supports, particularly for children with conditions such as cerebral visual impairment (CVI), retinopathy of prematurity, optic atrophy, or visual field loss.

These complex conditions do not always present as a traditional “eye problem” but can have a profound impact on how someone interprets the world, navigates space, and engages with others. When misunderstood or misclassified as purely medical, essential vision supports may be inadvertently excluded from NDIS plans.

This issue becomes especially apparent when families seek vision services such as orthoptic low vision assessments, vision therapy, assistive technology, orientation and mobility (O&M) training, or environmental adaptations, only to find that they fall outside the scope of current support pathways.

Yet, for people living with neurological vision impairment, these services are vital to building independence and safety.

Seven-year-old Maya is one such example.

Born extremely prematurely at just 23 weeks, Maya lives with cerebral palsy, epilepsy, and multiple forms of vision impairment, including bilateral optic atrophy, CVI, and severe visual field loss. A recent assessment of her functional vision showed a visual acuity of 6/24 with both eyes open and a visual efficiency of just 15%, factoring in visual field loss, contrast sensitivity, and visual processing difficulties.

For Maya, recognising faces, interpreting cluttered environments, and sustaining visual attention can be daily challenges. Her vision can appear to “switch off” when she’s overwhelmed or fatigued, affecting everything from learning in the classroom to safely navigating new spaces.

Without appropriate functional vision supports, children like Maya miss out on the chance to develop crucial life skills. These are the supports that can help them interpret visual cues, move through their environments safely, and participate in learning and play at a higher capacity.

Orthoptists are uniquely qualified to assess and support individuals with complex vision needs, particularly where neurological vision impairment is involved.

However, recent changes to NDIS legislation have made it increasingly difficult for participants to access orthoptic care, as these services are sometimes excluded or not clearly recognised within funding categories.

As a result, families are left navigating fragmented systems, often without access to the most appropriate vision professionals.

Despite Maya’s well-documented challenges, her requests for vision-related supports were not approved in her NDIS plan. The decision cited that her needs were already met through ophthalmology follow-up – a valuable medical service but one that does not provide the day-to-day functional support required to use vision effectively.

Similarly, it was suggested that an occupational therapist could provide orientation and mobility training, although such services require specific expertise and qualifications offered by Orientation and Mobility Specialists.

Maya’s case is not unique. Many families across Australia report similar experiences, particularly when the vision impairment stems from neurological causes. The need for better recognition of functional vision loss and specialist services within the NDIS is clear.

Fortunately, this represents a significant opportunity for positive change. Enhancing planner awareness, refining assessment processes, and ensuring access to qualified orthoptists and O&M specialists could make a meaningful difference for Australians living with low vision.

Recognising vision supports as functional, not just medical, would bring the NDIS into closer alignment with its core goal: to support people with disabilities to live ordinary lives.

With greater understanding and integration of vision services, children like Maya can receive the support they require to thrive, not just medically, but functionally, socially, and developmentally.

It is a small shift that could bring a lasting impact. 

About the Author: Jemila Kanu is the founder of In-Sight Vision Therapy in Perth. An orthoptist with more than 13 years of on-field experience, she is dedicated to supporting individuals living with visual impairments and neurological conditions.

More reading

Orthoptics Awareness Week 2024: Unleashing the potential of orthoptists

Vision Australia and Lions Outback Vision team up in Broome

Orthoptic-led clinics in private practice

Related Posts

The study concluded that clinicians should be aware of how cognitive limitations can lead to a reliance on "decisional shortcuts" that might bias decision-making. Image: rh2010/stock.adobe.com

Study supports rethink of IOP threshold in glaucoma treatment

by Staff Writer
January 16, 2026

New research has revealed that despite an evolving clinical understanding of glaucoma, many ophthalmologists continue to rely on the historical...

optometrists cyber-crimes

Smart glasses market tipped to hit $200b by 2040

by Rob Mitchell
January 16, 2026

Financial analysts are predicting rapid growth of the smart glasses market, with one global eyewear giant predicted to potentially double...

Sophi is an eco-conscious phaco system. Image: Rayner.

FDA clears Rayner’s Sophi device for US market

by Staff Writer
January 15, 2026

British ophthalmic equipment manufacturer Rayner has secured US Food and Drug Administration (FDA) clearance for Sophi, its Swiss-engineered phacoemulsification system....

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited